Review of Fructosyl Amino Acid Oxidase Engineering Research: A Glimpse into the Future of Hemoglobin A1c Biosensing

AUTOR(ES)

Ferri, Stefano

FONTE

Diabetes Technology Society

RESUMO

Glycated proteins, particularly glycated hemoglobin A1c, are important markers for assessing the effectiveness of diabetes treatment. Convenient and reproducible assay systems based on the enzyme fructosyl amino acid oxidase (FAOD) have become attractive alternatives to conventional detection methods. We review the available FAOD-based assays for measurement of glycated proteins as well as the recent advances and future direction of FAOD research. Future research is expected to lead to the next generation of convenient, simple, and economical sensors for glycated protein, ideally suited for point-of-care treatment and self-monitoring applications.

Documentos Relacionados

• A Review of the Challenge in Measuring Hemoglobin A1c
• A Review of Variant Hemoglobins Interfering with Hemoglobin A1c Measurement
• Influence of Variables on Hemoglobin A1c Values and Nonheterogeneity of Hemoglobin A1c Reference Ranges
• The Clinical Use of Hemoglobin A1c
• Distribution and properties of fructosyl amino acid oxidase in fungi.